Market-Moving News for November 18th
Market-Moving News for November 18th
RGNX: 30% | REGENXBIO shares are trading higher after the company announced dosing the first patient in its pivotal trial for Duchenne gene therapy.
RGNX: 30% | regenxbio股票交易價格上漲，因爲該公司宣佈對杜欠氏肌營養不良基因治療的關鍵試驗中第一位患者進行了投藥。
NIVF: 123% | NewGenIvf Inks Binding Term Sheet With California-Based Institutional Investor White Lion Capital, LLC, For $100M Equity Line Of Credit, Expandable To $500M
NIVF: 123% | NewGenIvf與加州機構投資公司White Lion Capital, LLC簽署了10000萬美元的股權授信框架協議，可擴大至5億美元。
ALDX: 10% | Aldeyra Therapeutics shares are trading higher after the FDA accepted its resubmitted new drug application for Reproxalap for the treatment of dry eye disease, prompting the company to announce an expansion of its option agreement with AbbVie.
ALDX: 10% | aldeyra therapeutics股票交易價格上漲，因爲美國食品藥品監督管理局接受了其重新提交的關於Reproxalap治療乾眼症的新藥申請，促使該公司宣佈擴大與艾伯維公司的期權協議。
譯文內容由第三人軟體翻譯。